Latest

First, the intrigue. Throughout the first day, I kept noticing this one person who harrumphed, guffawed, and muttered every time someone spoke in ways critical of the drug policy status quo. By accent, she seemed to be from the United States. And she had a yellow badge, where everyone else had a red badge. Who was she? Why did she keep shuffling over to the U.S. groups like Drug Free America and other cheerleaders for U.S. hardline policy? She settled in right behind me, and gave instructions to her allies — tactics for blocking inclusion of harm reduction. She said "one of you needs to interject to stop the hand clapping in favor of their proposals." More and more, she seemed like some sort of puppet master. As the day concluded, she rushed up to the podium, accosted the chair, and, in the most agitated way, began lambasting the chair for various procedural points.

I had to find out about the American woman with the yellow badge. At a social gathering later that evening, I described my observations to some of the NGO delegates who regularly attend these U.N. events. Turns out that the yellow-badge woman is June Sivilli, an employee of the U.S. drug czar’s office and a regular fixture at Vienna drug meetings. Until now, she has been able to speak as an official voice of the U.S. government — and the U.S. is always the most important voice on U.N. drug policy issues. Now that non-governmental organizations (NGOs) are bringing the voices of ordinary people to the table for the first time ever, she was actively subverting the process, throwing every possible obstacle in the way of this quite benign process.

I’d always heard that the U.S. government played a bully role in international drug policy. But it’s really ugly to see it in practice.

As an insider in the nation's war against drugs, I spent almost fifteen years in the executive office of the President. Eleven of these years were in the Office of National Drug Control Policy where I served four of the nation's so-called drug czars preparing the federal drug control budget, writing many of the national drug control strategies, and conducting performance measurement and analysis of the efficacy of those strategies.
…

In the latest 2008 National Drug Control Strategy, the Office of National Drug Control Policy (ONDCP) -- the federal executive office agency charged with shaping this nation's national drug control strategy -- claims that America has reached a turning point in the war on drugs. In reality, we have little reason to believe a significant change has occurred. ONDCP based its claim on declining use for youth -- a trend that long precedes this administration's tenure -- but ignores the lack of progress with regard to adult drug use, rates of drug addiction, the inaccessibility of substance abuse treatment, and new emerging drugs of demand such as pharmaceutical drugs and methamphetamine. If America is to be successful in the fight against drugs, the first priority for the next administration -- Republican or Democrat -- must be to reinventing ONDCP as an effective policy office capable of leading the nation's struggle with drugs.

That is basically the most polite possible way of saying these guys have their heads up their asses. It's a familiar sentiment, to be sure, but not what one typically hears from the guy who used to write the national drug control strategy.

To be clear, Carnevale is hardly the new poster child for drug policy reform. He simply wants to curtail our failed foreign drug war adventures and bring the money home to be spent on prevention and domestic law-enforcement. But his remarks serve to illustrate that there remains next to no one in America at this point who believes a single word the Drug Czar says. In this context, it seems likely that none of the people who've run that office into the ground over the past 8 years will still be working there in January regardless of who is elected president.

Update: Pete Guither has more over at DrugWarRant.